A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers

• Status: Completed
• Trial end date: 2005-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The hypothesis was to establish whether the use of PrevinC administered nasally 2-3 times a day will prevent upper respiratory infections in otherwise healthy adults working in child day care centers.

• Phase: Phase 4

Details

• Lead Sponsor: BioHealth Technologies Inc.

Criteria

Inclusion Criteria:

• Subject must provide written informed consent prior to the conduct of any study

• Male or female

• 18-65 years of age

• Inclusive

• Employed by one of seven selected Day Care Centers

Exclusion Criteria:

• Recent symptoms of upper respiratory infection, respiratory disease

• Received medication for colds or allergies within 3 weeks of enrolling

• Had nasal surgery within 2 months of enrolling

• Had a pierced nose or wore nose jewelry